Search results
More than 50 hospitalized after eating cucumbers that may be contaminated with salmonella
KTVK 3TV Phoenix· 3 hours agoThe recall was initiated after the Pennsylvania Department of Agriculture reported that a sample of...
Psychedelic-medicine stocks drop after ecstasy’s rocky day at the FDA
Market Watch· 9 hours agoPsychedelic-medicine stocks dropped sharply early Wednesday, a day after an independent panel of ...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
MPR News· 10 hours agoA panel of experts advising the Food and Drug Administration on the use of the psychedelic MDMA for post-traumatic ...
FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD
Scripps News via AOL· 7 hours agoA panel of advisers to the U.S. Food and Drug Administration has voted against the use of MDMA —...
FDA Panel Rejects MDMA Drug for PTSD
Medscape· 17 hours agoA US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic ...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
WHIO-TV 7 Dayton· 1 day agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
Adicet Bio gains FDA Fast Track for lupus nephritis treatment By Investing.com
Investing.com· 4 hours agoREDWOOD CITY, Calif. & BOSTON - Adicet Bio, Inc. (NASDAQ: ACET), a biotechnology firm in the...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 2 hours agoThe U.S. Food and Drug Administration is expected to use the committee’s recommendations to develop...
Will there be a new Covid vaccine in the fall?
NBC Universal via AOL· 1 hour ago"Will we regret not having been a little bit closer?" he added. The FDA is expected to make a final decision soon on which strain it will advise...
FDA panel rejects MDMA-based treatment for PTSD
The Hill· 19 hours agoA potential treatment for post-traumatic stress disorder (PTSD) using the psychedelic MDMA was overwhelmingly rejected by a panel of federal regulators...